Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?

European consensus conference on faecal microbiota transplantation in clinical practice

(2017) Giovanni Cammarota et al.   GUT

Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor–Dependent Repression of Claudin-2

(2017) Leon Zheng et al.   JOURNAL OF IMMUNOLOGY

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

(2017) Ruixin Liu et al.   NATURE MEDICINE

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”

(2017) Anne-Katrin Pröbstel et al.   Neurotherapeutics

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

(2017) Luanne M. Metz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

(2017) Egle Cekanaviciute et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

(2017) Kerstin Berer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vitamin D and multiple sclerosis: An update

(2017) Charles Pierrot-Deseilligny et al.   Multiple Sclerosis and Related Disorders

EBV and MS: Major cause, minor contribution or red-herring?

(2017) Sean Burnard et al.   Multiple Sclerosis and Related Disorders

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study

(2017) Marina Saresella et al.   Frontiers in Immunology

High frequency of intestinal T H 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis

(2017) Ilaria Cosorich et al.   Science Advances

Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology

(2017) Lea Bircher et al.   Microbial Biotechnology

Fecal microbiota transplant in patients with Clostridium difficile infection

(2016) Brandon C. Chapman et al.   Journal of Trauma and Acute Care Surgery

Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study

(2016) Maria Chiara Buscarinu et al.   Multiple Sclerosis Journal

Fecal microbiota transplant in patients with Clostridium difficile infection

(2016) Brandon C. Chapman et al.   Journal of Trauma and Acute Care Surgery

Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study

(2016) Maria Chiara Buscarinu et al.   Multiple Sclerosis Journal

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial

(2016) Vijayshree Yadav et al.   Multiple Sclerosis and Related Disorders

Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders

(2016) Alper Evrensel et al.   Clinical Psychopharmacology and Neuroscience

Systematic Review: Adverse Events of Fecal Microbiota Transplantation

(2016) Sinan Wang et al.   PLoS One

Fecal microbiota transplantation broadening its application beyond intestinal disorders

(2015) Meng-Que Xu   WORLD JOURNAL OF GASTROENTEROLOGY

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

(2015) Sachiko Miyake et al.   PLoS One

Therapeutic Potential of Fecal Microbiota Transplantation

(2013) Loek P. Smits et al.   GASTROENTEROLOGY

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

(2013) Yukihiro Furusawa et al.   NATURE

Reprogramming of Murine Macrophages through TLR2 Confers Viral Resistance via TRAF3-Mediated, Enhanced Interferon Production

(2013) Darren J. Perkins et al.   PLoS Pathogens

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

(2011) Ethan Gough et al.   CLINICAL INFECTIOUS DISEASES

Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients

(2011) Colleen R. Kelly et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The impact of environmental infections (parasites) on MS activity

(2011) Jorge Correale et al.   Multiple Sclerosis Journal

Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study

(2011) JO Fleming et al.   Multiple Sclerosis Journal

Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells

(2009) Jing Zhang et al.   ACTA PHARMACOLOGICA SINICA

Effects ofBifidobacterium animalisadministered during lactation on allergic and autoimmune responses in rodents

(2008) J. Ezendam et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY